Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 ...

More than 200 students from various educational institutions across Kerala, along with working professionals, vied for honours in the state-level ‘Generative AI Hackathon 2025’ held at Technopark here ...

Karikku Web Series Star Kiran Viyyath Ties The Knot With Athira, Co-Stars Shar.. Ronth X Review: What Audiences Are Saying About Dileesh Pothan And Roshan Math.. Vyasanasametham Bandhumithradhikal ...

In a challenging year for Athira Pharma Inc., the biotechnology firm's stock has plummeted to a 52-week low, touching down at $0.41. According to InvestingPro data, while the... Robert Renninger ...

Founded in 2011 under the name M3 Biotechnology, Athira has been trying to develop small molecule drugs that help regenerate nerve cells and slow their erosion from diseases like Alzheimer’s and ...

A clinical-stage biopharma company developing small molecules to restore neuronal health and slow neurodegeneration. Athira's product candidates seek to provide rapid cognitive improvement and alter ...

Athira Pharma’s tumultuous journey to phase 2/3 Alzheimer’s disease data has ended in failure. The trial found fosgonimeton was no better than placebo on the primary and key secondary ...

Athira Pharma takes a small-molecule approach to targeting the neurotrophic hepatocyte growth factor (HGF) system for neurodegenerative diseases. Athira has reached late-stage development of its lead ...

BOTHELL, Wash., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health ...